Source: ERJ Open Res, 6 (4) 00356-2020; 10.1183/23120541.00356-2020
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Steffen D. Kriechbaum, Lillith Scherwitz, Christoph B. Wiedenroth, Felix Rudolph, Jan-Sebastian Wolter, Moritz Haas, Ulrich Fischer-Rasokat, Andreas Rolf, Christian W. Hamm, Eckhard Mayer, Stefan Guth, Till Keller, Stavros V. Konstantinides, Mareike Lankeit, Christoph Liebetrau. Mid-regional pro-atrial natriuretic peptide and copeptin as indicators of disease severity and therapy response in CTEPH. ERJ Open Res, 6 (4) 00356-2020; 10.1183/23120541.00356-2020

Member's Comments

No comment yet.

Related content which might interest you: Midregional pro-atrial natriuretic peptide and procalcitonin improve survival prediction in VAP Source: Eur Respir J 2011; 37: 595-603 Year: 2011 The prognostic value of repeated measurements of N-terminal pro-B-type natriuretic peptide in patients with pulmonary hypertension Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects Year: 2010 The use of plasma n-terminal pro B-type natriuretic peptide (proBNP) concentrations in differential diagnosis of comorbidity pulmonary patients Source: Annual Congress 2011 - Acute respiratory failure Year: 2011 Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia Source: Eur Respir J 2007; 30: Suppl. 51, 481s Year: 2007 The role of pro-brain natriuretic peptide and C-reactive protein as prognostic markers in stable COPD Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 Validation of N-terminal pro-brain natriuretic peptide cut-off values for risk stratification of pulmonary embolism Source: Eur Respir J 2014; 43: 1669-1677 Year: 2014 Plasma n-terminal pro-brain natriuretic peptide (NT pro-BNP) level in respiratory diseases Source: Eur Respir J 2003; 22: Suppl. 45, 583s Year: 2003 Diagnostic value of N-terminal pro-brain natriuretic peptide in patients with COPD with chronic hypoxemic respiratory failure. Source: Virtual Congress 2020 – COPD and the impact of comorbidities Year: 2020 Pro-adrenomedullin, pro-atrial natriuretic peptide and procalcitonin levels at admission in patients with community-acquired pneumonia and its correlation with risk scores Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Prognostic significance of amino-terminal pro-brain natriuretic peptide testing among waitlisted lung transplant candidates Source: Virtual Congress 2021 – Challenging problems in lung transplantation Year: 2021 Brain natriuretic peptide (BNP) levels during acute exacerbations of COPD – a novel biomarker Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host Year: 2008 Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension Source: Eur Respir J 2010; 35: 95-104 Year: 2010 The diagnostic value of N-terminal pro-C-type natriuretic peptide in COPD patients with pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015 Brain natriuretic peptide (BNP) determination in patients hospitalized for COPD exacerbation Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Correlation of levels of N-terminal pro-B-type natriuretic peptide with localization of thrombus in acute pulmonary embolism Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism Year: 2011 N-terminal-pro-B-type natriuretic peptide (NT-proBNP) in patient with acute exacerbations (AE) of COPD Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 N-terminal pro-brain natriuretic peptide is a useful prognostic marker in patients with pulmonary hypertension and renal insufficiency Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 Can brain natriuretic peptide (BNP) be a predictor for pulmonary arterial hypertension? Source: Annual Congress 2007 - Pulmonary hypertension: diagnosis and treatment Year: 2007 Levels of procalcitonin, neopterin, C-reactive protein and pro-atrial natriuretic peptide in patients with community-acquired pneumonia and its kinetic according to the severity and the development of complications Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections Year: 2010 N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism Source: Eur Respir J 2003 Oct 01;22(4):649-653 Year: 2003